Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy.
about
Topical lidocaine for neuropathic pain in adultsDiabetic neuropathic pain: Physiopathology and treatmentAdministration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes MellitusTreating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy.Systematic review of treatments for diabetic peripheral neuropathy.Burning through the pain: treatments for diabetic neuropathy.Management of chronic neuropathic pain: a protocol for a multiple treatment comparison meta-analysis of randomised controlled trials.Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathyDouble-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy.Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trialA randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic painSynthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agentsSystematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury.Use of natural compounds in the management of diabetic peripheral neuropathy.Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions.Topical analgesics for neuropathic pain in the elderly: current and future prospects.Efficacy of α-lipoic acid in diabetic neuropathy.Prior authorization in the treatment of patients with pDPN and FM.Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials.Drugs for the treatment of peripheral neuropathies.Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.Carbonic anhydrase inhibition and the management of neuropathic pain.Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials.Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers.Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.Training and Practices of Cannabis Dispensary StaffTherapeutic potential for leukocyte elastase in chronic pain states harboring a neuropathic component.Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis.Mirogabalin and emerging therapies for diabetic neuropathy
P2860
Q24194814-B662E596-4B5E-4BBB-ACC0-A4284D8F064AQ27004604-FCDEEAB6-0ACF-45CB-8500-AA24AB9B401EQ28072087-244D0D0C-BCF9-475C-AC2B-13474A5D2D5BQ33583006-4D2190E7-12C2-46F5-9D1A-17E3422C973AQ33921692-30EAEA2C-F8CF-429C-844A-8D576E21501CQ34161497-F42F5F6E-7821-4401-80CB-C04C4216A3BBQ34485306-7522F4EF-6083-4353-8251-F4D57BE6FF5EQ34573490-933AD801-AE65-4BE6-8127-60DBFB0BF13CQ34855100-F7769BAE-E860-4C5B-8705-787D819D6EA0Q35619182-E9DB8654-8BC0-4D9E-8D15-2A9EF56EBD0BQ35911519-5D004EAC-17C4-4AF5-8725-679353A1E560Q36628308-4F36A646-A982-4AC7-8B25-0BC8F9F62832Q37258925-0270DCE5-4A58-4EF2-9D94-BFC389416155Q38123153-349DD090-FA9A-4673-8371-2ACA864340A1Q38194034-CF2C7D8F-FD3B-4F38-BCBE-FC720DD29A44Q38201876-E99AB97D-44CF-4DD9-8004-FF7BFE3275F3Q38265422-2AF471D1-2498-4081-A446-CAC90E6E475DQ38266297-9DC9AA06-3444-4150-BE06-9C647E720EF9Q38267189-4AC20878-7503-42EF-8850-59DC04A95051Q38631470-6805D577-96F0-4383-8D9E-42DBC1B1B4E1Q38633190-943581EE-4BDD-4F71-885C-6F4FFD7048C3Q38798588-C20D7CCE-E607-4EAC-9598-71CF9D9092D3Q38841249-346EC1C7-F0C5-4619-84AC-FBD20BB0BB04Q39167580-ED75A184-555D-4075-B057-C59B576D3CABQ39252064-39FED39E-9BC2-4AF0-AB02-D9D71B4F34ADQ39289330-9EBDD4DD-278B-4628-9ACE-F9A640DAC42DQ41152416-587FA489-73FE-4A5E-92C6-C56A72D74B9AQ42699156-DB2334CC-09FB-48D1-9DCB-DD4139DAD4B5Q46436575-85F920F9-AA23-49F6-846C-06E8E68F5873Q50775835-89A2F478-0189-466A-B7DC-D1F335424CF4Q58720069-86BA8D9E-62D8-4F8B-B31D-E51C2AC31A95
P2860
Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systematic review and meta-ana ...... iabetic peripheral neuropathy.
@en
type
label
Systematic review and meta-ana ...... iabetic peripheral neuropathy.
@en
prefLabel
Systematic review and meta-ana ...... iabetic peripheral neuropathy.
@en
P2093
P2860
P356
P1433
P1476
Systematic review and meta-ana ...... iabetic peripheral neuropathy.
@en
P2093
Alesia Sadosky
Joseph C Cappelleri
Lavanya Sudharshan
Marc Botteman
Sonam Mehta
Sonya J Snedecor
P2860
P304
P356
10.1111/PAPR.12054
P577
2013-03-28T00:00:00Z